Updates

Date: July 08, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM Subject: Intimation of letter to Shareholders whose e-mail addresses are not registered with Company/Registrar & Transfer Agent/Depository Participants Dear Sir/Madam, Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Anthem Biosciences Limited ("the Company") has dispatched letters to those Shareholders whose email addresses are not registered with the Company, the Registrar and Transfer Agent, or their respective Depository Participants. The letter provides the web link to the Company's website from which the Annual Report for FY 2025-26 can be accessed. A copy of the draft letter is enclosed herewith for your record. You are requested to kindly take the above information on your records. Yours truly, For Anthem Biosciences Limited Divya Prasad Company Secretary & Compliance Officer Membership No: A41438 Open PleaseTear Here Open PleaseTear Here अंतद(cid:337)शीय प(cid:361) काड(cid:330) INLAND LETTER CARD If undelivered please return to :- KFin Technologies Limited UNIT: Anthem Biosciences Limited Selenium Tower B, Plot No. 31 & 32, Gachibowli, Financial District, Nanakramguda, Hyderabad: 500 032 Toll Free No: 1800 309 4001 Email:einward.ris@kfintech.com Anthem Biosciences Limited (Formerly Known as Anthem Biosciences Private Limited) CIN: L24233KA2006PLC039703 Registered Office: 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase I, Bommasandra, Bangalore, Karnataka, India - 560099 Email: investors.abl@anthembio.com|Website: https://www.anthembio.com/ Date: 03/07/2026 Folio Number.: 19101 - 1201910100102989 Dear Shareholder, Subject: Notice of the 20th (Twentieth) Annual General Meeting of Anthem Biosciences Limited along with Web Link and Exact Path for Accessing the Annual Report for FY 2025–26 We are pleased to inform you that 20th (Twentieth) Annual General Meeting ("AGM/e-AGM") of the Members of the Anthem Biosciences Limited is scheduled to be held on Wednesday, July 22, 2026, at 03.30 P.M. IST through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM") to transact the business as set out in notice. The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) (Third Amendment) Regulations, 2024, notified on December 12, 2024, have amended Regulation 36(1)(b) of the SEBI (LODR) Regulations, 2015. Pursuant to the said amendment, the requirement to send a hard copy of the statement containing the salient features of the documents referred to under Section 136 of the Companies Act, 2013 has been replaced with the requirement to send a communication providing the web link, including the exact path, where the complete Annual Report is available. Accordingly, the Annual Report of Anthem Biosciences Limited for the Financial Year 2025–26 is available at the following web link: Web Link: https://anthembio.com/wp-content/uploads/2026/06/Annual-Report-FY-2025-2026.pdf Exact Path: www.anthembio.com → Investors → Reports → Annual Reports → Annual Report FY 2025–26 You are requested to access the Annual Report using the above web link or by following the exact path provided. This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any of the Depository or with the RTA of the Company. Further, it is requested to update your e-mail address at the earliest through your depository participants to continue receiving all important information & documents thereafter. Thank you for your continued support. Yours faithfully, For Anthem Biosciences Limited Sd/- Divya Prasad Company Secretary & Compliance Officer